Xeno Transplants Corp. operates as a bio-technology research and development company. It intends to develop therapeutic applications of organs and cells derived from genetically engineered pigs as a transplant alternative to limited human donor sources. The company was founded on October 5, 2004 and is headquartered in Vancouver, Canada.